Courage Against Cancer
At Courage Against Cancer (CAC), we believe every patient deserves evidence-based answers to the questions that matter most — including whether fenbendazole has a legitimate place in cancer research conversations. In 2025 and 2026, the scientific dialogue around this repurposed antiparasitic dru…
At Courage Against Cancer (CAC), we believe patients deserve honest, evidence-based information about emerging research. As interest in this antiparasitic drug has surged following the viral Joe Tippens story, the gap between online claims and actual clinical data has become critical to understand.
At Courage Against Cancer (CAC), we believe every patient deserves evidence-based answers to the pillar article primary question: Does fenbendazole have a meaningful role in cancer care? Current research exists along a spectrum — from promising laboratory findings to limited human data.
At Courage Against Cancer (CAC), we believe every patient deserves evidence-based answers to the central question driving this conversation: Does fenbendazole have a legitimate role in colorectal cancer care? The honest answer in 2026 is nuanced — early-stage laboratory findings are genuinely in…
At Courage Against Cancer (CAC), we believe every cancer patient deserves honest, evidence-based answers to the most pressing questions — including this one. Fenbendazole, a veterinary anthelmintic, has generated significant interest through anecdotal stories, but mainstream oncology has not yet endorsed it.
At Courage Against Cancer (CAC), we believe patients deserve evidence-based answers to the real questions they’re asking — including whether human clinical trials on fenbendazole for colorectal cancer exist in 2026. The short answer: formal, large-scale human trials remain extremely limited.